Seoyeon Choi
Papers
1
Total Citations
12
H-Index
1
About
Dr. Seoyeon Choi is pioneering the next frontier of cancer immunotherapy through her groundbreaking work in biohybrid microrobotics and targeted cellular delivery. Her research lies at the intersection of nanomedicine, immunology, and micro-robotics, with a primary focus on engineering natural killer (NK) cells as intelligent, drug-free therapeutic platforms. In her most cited work, "pH‐Sensitive Magnetic Nanoparticle‐Mediated Natural‐Killer‐Cell‐Based Microrobots for Dual‐Targeted Delivery and Induction of Pro‐Inflammatory Macrophage Polarization" (2024, 12 citations), Dr. Choi addresses a critical limitation of NK cell therapy—weak tumor targeting—by equipping cells with pH-responsive magnetic nanoparticles. This innovation enables dual-targeted delivery: magnetic guidance to the tumor site and pH-triggered release, while simultaneously polarizing macrophages toward a pro-inflammatory, anti-tumor state. Her approach represents a paradigm shift, moving beyond traditional chemotherapeutic payloads to harness the innate killing power of immune cells. Though early in her career, Dr. Choi’s work is already recognized for its translational potential, offering a scalable, multifunctional strategy that could redefine adoptive cell therapy and bring us closer to precision cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1